Entera Bio Ltd
NASDAQ:ENTX 11:24:20 AM EDT
| Market Cap (Intraday) | 120.78M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.46 |
| 50-Day MA | $4.75 |
| 200-Day MA | $3.83 |
Entera Bio Ltd Stock, NASDAQ:ENTX
Kiryat Hadassah, Minrav Building, Jerusalem, Jerusalem 9112002
Israel
Phone: +972.2.532.7151
Number of Employees: 18
Description
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. It develops an oral formulation of parathyroid hormone. The company was founded on June 1, 2010 and is headquartered in Jerusalem, Israel.